CRP Induces NETosis in Heart Failure Patients with or without Diabetes.


Journal

ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159

Informations de publication

Date de publication:
09 08 2019
Historique:
received: 27 03 2019
accepted: 23 07 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 27 2 2020
Statut: epublish

Résumé

C-reactive protein (CRP) is recognized as a biomarker of chronic, low-grade inflammation associated with vascular disorders. Lately, the role of neutrophils and neutrophil extracellular traps (NETs) has been investigated as a potential source of chronic inflammation and cardiovascular complications. This study investigated NETs as a marker of inflammation in patients with symptomatic heart failure (HF) with or without type 2 diabetes (T2DM) and examined the correlation between NETs and CRP. We performed a noninterventional study including patients with HF with or without T2DM, T2DM, and a healthy control (HC) group. NETs and other inflammatory markers in serum were measured by ELISA. The release of NETs (NETosis) in vitro under various stimuli was measured by confocal microscopy. The levels of NETs in the serum of HF patients were significantly higher compared with HC (112%). Serum CRP concentrations were significantly increased in HF and HF plus T2DM patients compared with HC, and a positive correlation was observed between serum CRP and NETs levels. Neutrophils from HF and HF plus T2DM patients underwent in vitro NETs release faster than T2DM and HC without any stimuli. In vitro, serum collected from the HF and the HF plus T2DM group induced NETosis in healthy neutrophils significantly more when compared with HC and T2DM, which was prevented by depletion from CRP. We confirmed in vitro that CRP induces a concentration-dependent NETs synthesis. This study proposes a mechanism by which CRP increases the risk of future cardiovascular events and supports mounting evidences on the role of neutrophils in chronic low-grade inflammation associated with HF.

Identifiants

pubmed: 31399487
pii: 3/8/378
doi: 10.4049/immunohorizons.1900026
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-388

Subventions

Organisme : CIHR
ID : MOP-97943
Pays : Canada

Informations de copyright

Copyright © 2019 The Authors.

Auteurs

Branka Vulesevic (B)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada.
Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Simon S Lavoie (SS)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada.
Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Paul-Eduard Neagoe (PE)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada.

Elizabeth Dumas (E)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada.
Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Agnès Räkel (A)

Département de Médecine, Faculté de Médecine, Université de Montréal, Montreal, Quebec 3T 1J4, Canada; and.
Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H2X 0A9, Canada.

Michel White (M)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada.
Département de Médecine, Faculté de Médecine, Université de Montréal, Montreal, Quebec 3T 1J4, Canada; and.

Martin G Sirois (MG)

Centre de Recherche, Institut de Cardiologie de Montréal, Faculté de Médecine, Université de Montréal, Montreal, Quebec H1T 1C8, Canada; martin.sirois@icm-mhi.org.
Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH